cp wire

CP Wire Articles

LivaNova Releases Safety and Technical Information for Valve-in-Valve Procedures on Its Perceval Platform

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, announced on 2/25/19 that given the increasing viability of Valve-in-Valve (ViV) procedures, it has added new safety and... read more

Mon, 02/25/19 - 09:58 am
Imbrium Therapeutics and Mundipharma EDO Announce Orphan Drug Designation for Relapsed Refractory Biliary Tract Cancer Treatment



Imbrium Therapeutics L.P., an operating subsidiary of Purdue Pharma L.P., in conjunction with Mundipharma EDO GmbH, announced on 2/21/19 that the U.S. Food and Drug Administration (FDA)... read more

Fri, 02/22/19 - 09:46 am
Outlook Therapeutics Files for $57 Million Offering

On 2/21/19 Outlook Therapeutics filed for a $57 million offering in part to support its treatment for wet AMD (age related macular degeneration). The filing did not specify the number of shares to... read more

Thu, 02/21/19 - 10:49 am
Microbiome Report for Week Ending 2/16/19

SkinBioTherapeutics to Seeking New CEO
On 2/14/19 SkinBioTherapeutics... read more

Wed, 02/20/19 - 02:23 pm
Pfizer drops higher dose treatment arm in Xeljanz post-marketing study due to safety issues

Pfizer’s Xeljanz (tofacitinib), used to treat conditions such as rheumatoid arthritis and ulcerative colitis, has... read more
Wed, 02/20/19 - 11:50 am

Pages